Fermi Inc. Wins Sale Fight and Court Battle, 12% Still Short
Fermi Inc. rejected an ex-CEO's full-sale proposal and won a Texas court ruling protecting its voting rules, preserving board independence while a 12.4% short float and unresolved Project Matador subp
Fermi Inc. Wins Sale Fight and Court Battle, 12% Still Short
NEW YORK, September 18 —
Fermi Inc. (FRMI) won a Texas court ruling on voting rules and rejected an ex-CEO's full-sale push, with 12.4% of its float still short.
- Texas Business Court denied all requests to block Fermi's voting rules and nomination deadline, closing off both procedural paths the ex-CEO pursued
- FRMI trades at 38.3x forward P/E with trailing EPS at -$1.46; at $4.98, the stock prices a transformation management must now deliver
- Next data point: next shareholder meeting date and any amended 13D filings from the ex-CEO confirming whether a full proxy fight follows
Ex-CEO Now Faces the Vote He Tried to Avoid
The Texas Business Court denied not one but both requests: blocking Fermi's voting rules and blocking the nomination deadline. That is a comprehensive shutout, not a partial setback. The ex-CEO's procedural playbook relied on using the courts to stall or reshape the vote before it happened. That option is now closed.
Shares gapped up on the news, consistent with activist pressure deflating. But the gap-down two days earlier on Project Matador subpoena news is visible in the chart. The legal calendar has more than one open entry.
38.3x Forward P/E on Negative Trailing EPS: The Board Just Bet on Itself
At $4.98 and 38.3x forward P/E, FRMI is not a stock the market is pricing for distress. Trailing EPS at -$1.46 tells a different story. The gap between those two numbers is the board's entire investment thesis: that a current money-loser is on a trajectory the forward multiple already reflects.
Rejecting a full sale at these prices is a high-conviction call. The FRMI fundamentals page shows the full balance sheet picture. If management is right, the current price is a floor. If they are wrong, there is no strategic buyer waiting in reserve.
Project Matador Subpoena: The Risk the Gap-Up Did Not Erase
Two days before the court victory, FRMI dropped on news of a Project Matador subpoena that rattled traders. That story has not resolved. The board's win on voting procedures is a separate legal track entirely. Investors treating Thursday as a clean sweep are pricing two distinct legal risks as one.
Legal costs, management distraction, and the subpoena overhang persist even if the activist proxy battle fades. That is the sleeper risk in a stock already trading at a premium to its current earnings.
12.4% Short Float: Fuel for a Squeeze if the Activist Folds
More than one in eight shares of FRMI's float is short. In a scenario where the ex-CEO files no further 13D amendments and the proxy fight loses momentum, short covering can amplify any rally well beyond what operating fundamentals support at $4.98. The gap-up may have already squeezed some of that out.
The number that would prove the bull case wrong next quarter: escalating short interest or a new activist filing. Neither arrived Thursday. But 12.4% short is not a crowd that has given up.
A full Basis Report analysis on FRMI with a BUY rating is available at the Fermi Inc. research report; investors who want to stress-test the valuation independent of the activist noise can model it directly with the DCF calculator.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Fermi Inc. (FRMI) rejected an ex-CEO's call for a full company sale while a Texas court denied attempts to block the company's voting rules and nomination deadline.
Sources & Filings